Literature DB >> 28330753

Rationale and study protocol for the Patient-Centered Outcome Aid (PCOA) randomized controlled trial: A personalized decision tool for newly diagnosed ovarian cancer patients.

L Wenzel1, D Mukamel2, K Osann2, L Havrilesky3, L Sparks4, J Lipscomb5, A A Wright6, J Walker7, R Alvarez8, L Van Le9, K Robison10, R Bristow2, R Morgan11, B J Rimel12, H Ladd2, S Hsieh2, A Wahi2, D Cohn13.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28330753      PMCID： PMC6198815          DOI： 10.1016/j.cct.2017.03.006

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN： 1551-7144            Impact factor:   2.226


× No keyword cloud information.
  31 in total

Review 1.  Framework for teaching and learning informed shared decision making.

Authors:  A Towle; W Godolphin
Journal:  BMJ       Date:  1999-09-18

2.  Informed and shared decision-making: the crux of patient-centered care.

Authors:  W W Weston
Journal:  CMAJ       Date:  2001-08-21       Impact factor: 8.262

3.  Information needs and decisional preferences among women with ovarian cancer.

Authors:  D E Stewart; F Wong; A M Cheung; J Dancey; M Meana; J I Cameron; M P McAndrews; T Bunston; J Murphy; B Rosen
Journal:  Gynecol Oncol       Date:  2000-06       Impact factor: 5.482

4.  Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice.

Authors:  David E Cohn; Laura J Havrilesky; Kathryn Osann; Joseph Lipscomb; Susie Hsieh; Joan L Walker; Alexi A Wright; Ronald D Alvarez; Beth Y Karlan; Robert E Bristow; Paul A DiSilvestro; Mark T Wakabayashi; Robert Morgan; Dana B Mukamel; Lari Wenzel
Journal:  Gynecol Oncol       Date:  2015-07-12       Impact factor: 5.482

5.  Cancer patients' information needs and information seeking behaviour: in depth interview study.

Authors:  G M Leydon; M Boulton; C Moynihan; A Jones; J Mossman; M Boudioni; K McPherson
Journal:  BMJ       Date:  2000-04-01

6.  Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Authors:  D S Alberts; P Y Liu; E V Hannigan; R O'Toole; S D Williams; J A Young; E W Franklin; D L Clarke-Pearson; V K Malviya; B DuBeshter
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

7.  Reliability and validity of the functional assessment of cancer therapy-ovarian.

Authors:  K Basen-Engquist; D Bodurka-Bevers; M A Fitzgerald; K Webster; D Cella; S Hu; D M Gershenson
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

Review 8.  Patient preferences for shared decisions: a systematic review.

Authors:  Betty Chewning; Carma L Bylund; Bupendra Shah; Neeraj K Arora; Jennifer A Gueguen; Gregory Makoul
Journal:  Patient Educ Couns       Date:  2011-04-06

9.  Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: a Gynecologic Oncology Group study.

Authors:  Lari Wenzel; Helen Q Huang; David Cella; Joan L Walker; Deborah K Armstrong
Journal:  Gynecol Oncol       Date:  2008-04-21       Impact factor: 5.482

10.  Cancer patients: their desire for information and participation in treatment decisions.

Authors:  H J Sutherland; H A Llewellyn-Thomas; G A Lockwood; D L Tritchler; J E Till
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000
View more
  3 in total

1.  Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-02-05

2.  Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Thomas J Lyons; Richard J Goodall; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2019-10-31

3.  Neoadjuvant chemotherapy before surgery versus surgery followed by chemotherapy for initial treatment in advanced ovarian epithelial cancer.

Authors:  Sarah L Coleridge; Andrew Bryant; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.